Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000259192 encodes a pseudogene related to the carboxy-terminal domain (CTD) small phosphatase 2 (CTDSP2)[1][3]. Pseudogenes are genomic DNA sequences similar to normal genes but typically nonfunctional due to mutations or lack of regulatory sequences necessary for expression[1][3]. Consequently, this pseudogene does not encode a functional protein and is not known to have a direct biological function, therapeutic role, disease association, or drug interactions. Note: - The canonical functional gene is “CTD small phosphatase 2” (CTDSP2, ENSG00000145431), which is an enzyme with phosphatase activity important in regulating transcription by RNA polymerase II[4][6][9]. - ENSG00000259192 specifically refers to its pseudogene, which is not a therapeutic target, does not produce protein, and is not clinically actionable. - If structured information is required for a therapeutic or functional entity, information about CTDSP2 (not the pseudogene) should be used instead[4][6][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CTD small phosphatase 2 pseudogene.